Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Vasopressin Effects on Delta-beta Coupling
NCT06605300Completed
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Oct 2024
- Primary completion
- Jul 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray and vasopressin in anxiety disorder (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Resting-state EEG Delta-beta Cross-frequency Coupling, Behavioral Indices in Tasks and 1 more. Started Oct 2024; status: completed.
02
Drugs
oxytocin nasal sprayvasopressin
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT06605300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605300.